Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Femtobiomed

Request full access

Multiplexed cell engineering solutions for decentralized cell therapy manufacturing

Seongnam-si, South KoreaFounded 2011Fintech

About Femtobiomed

Femtobiomed operates in the biotechnology sector, focusing on providing advanced solutions for cell therapy manufacturing. The company specializes in multiplexed cell engineering, utilizing partitioned flow transfection technology to enhance targeted gene delivery. This approach aims to empower researchers and clinicians by unlocking new possibilities in cell therapy, ultimately shaping the future of healthcare. Femtobiomed's business model revolves around offering cutting-edge devices and support to facilitate decentralized cell therapy manufacturing, catering primarily to researchers and clinicians in the healthcare industry. The company generates revenue through the sale of its specialized devices and associated services, positioning itself as a key player in the cell therapeutics market.

Source: Dealroom company data

At a glance

Status
Operational
Employees
15
Open positions
None listed
Dealroom signal
51.0/100
Industry
Fintech, Marketing

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2022 $16M $65M Yukyung PSG Asset Management ↗
OtherOther financing Jan 2015 $0 — ActnerLab ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Femtobiomed website traffic

Latest recorded traffic for Femtobiomed is 1.4K monthly website visits, up 7.7% over the last three months.

Latest monthly visits1.4K 3-month web change+7.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Femtobiomed in the Seongnam-si ecosystem

Live from Dealroom

The Femtobiomed office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • Yukyung PSG Asset Management

Other known investors3 additional known investors

  • ActnerLab
  • ABC partners
  • Korea Investment Partners
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇰🇷 South Korea100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Femtobiomed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Femtobiomed’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.